Investing

Biohaven : BHVN

BHVN

Stock Data

$9.63

$0.04 (0.42%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Biohaven Ltd is a biopharmaceutical company based in New Haven, Connecticut, dedicated to advancing treatments in immunology, neuroscience, and oncology. With a robust pipeline, Biohaven is actively working on developing therapies for a range of conditions including neurological disorders, spinal muscular atrophy, obesity, epilepsy, bipolar disorder, major depressive disorder, migraines, neuropathic pain, Alzheimer's, Parkinson’s disease, rheumatoid arthritis, and various cancers. The company collaborates with prestigious institutions like Yale University and AstraZeneca to bring innovative solutions from the lab to the patients who need them.

All Biohaven Articles

10 Articles

Ian Cooper | Feb 9, 2026 at 9:26 AM EST

Goldman Sachs Just Upgraded These 3 Stocks to a Buy Rating

It’s always a good idea to pay close attention to analyst upgrades. Often, they’re influenced by (1) company fundamentals, such…

Lee Jackson | Feb 6, 2026 at 8:07 AM EST

Here Are Friday’s Top Wall Street Analyst Research Calls: Amazon.com, Caterpillar, Estee Lauder, JPMorgan, Norfolk Southern, Roku, Snap, Vistra, and More

Pre-Market Stock Futures: Futures are trading higher as we prepare to wrap up one of the worst trading weeks in…

Lee Jackson | Dec 3, 2025 at 8:15 AM EST

Here Are Wednesday’s Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy’s and More

Pre-Market Stock Futures: Futures are trading lower on Wednesday after an ADP report showing job losses, following a stellar day…

Lee Jackson | Nov 26, 2025 at 8:06 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: DHL Group, NetApp, Nutanix, Oracle, Snowflake, Urban Outfitters, Zscaler and More

Pre-Market Stock Futures: The futures are trading modestly higher as Thanksgiving Eve has finally arrived. After a slow start on…

Trey Thoelcke | Nov 18, 2025 at 8:45 AM EST

Carl Icahn Makes Another Huge Insider Purchase

Carl Icahn has made another huge bet, boosting his stake in a utility infrastructure company. It was not the only…

Trey Thoelcke | Apr 28, 2024 at 8:15 AM EDT

These Biotechs and IPOs Inspire Big Insider Buying

Initial public offerings and a secondary offering inspired insiders to pick up some shares of these biotech companies and others.

Lee Jackson | Oct 27, 2022 at 8:52 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Halliburton, Invesco, Mattel, Netflix, Roblox, Synchrony, Visa and More

Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Biohaven, Edwards Lifesciences, Enphase Energy, Halliburton, Invesco, Liberty Energy, Mattel, Netflix,…

Chris Lange | Oct 26, 2022 at 12:35 PM EDT

Big Tech Disappointments: Analysts Upgrade or Downgrade Canopy Growth, Roku and Others

Wednesday’s additional top analyst upgrades and downgrades were on Ally Financial, Baker Hughes, Biohaven, Biogen, Bumble, Canopy Growth, Corning, Discover…

Chris Lange | Aug 19, 2022 at 12:40 PM EDT

Meme Stock Madness: Analysts Upgrade or Downgrade Meta Platforms, Occidental Petroleum and More

Friday's additional top analyst upgrades and downgrades were on Applied Materials, Dick’s Sporting Goods, Foot Locker, HP, Meta Platforms, Occidental…

Chris Lange | Aug 10, 2021 at 12:56 PM EDT

Tuesday Afternoon Analyst Upgrades and Downgrades: SmileDirectClub, Squarespace, Victoria’s Secret and More

24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including…